Metformin and methylene blue: cheap biohacking longevity trend

Metformin and methylene blue: the €2 biohacking trend

A customer asks for blue dye to tint t-shirts. The pharmacist suspects nothing: 25 grams of powdered methylene blue for between €10 and €12. The other half of the method is dispensed a few meters away at €2 per box: metformin, the standard antidiabetic drug for type 2 diabetes. This is the offer circulating: two extremely cheap products claimed to help people live longer and better.

The fine print, as almost always, tells a different story. Between mitochondrial promises and laboratory technician warnings lies a huge gap, and that gap is the only certainty in this matter.

What is metformin and why is it linked to longevity?

Metformin is a classic antidiabetic drug. The clue that turned it into an object of worship is statistical: type 2 diabetics live longer on average, excluding those with uncontrolled disease, and some attribute this extra lifespan directly to the pill. The hypothesis has a biochemical basis that can be stated without hype: the drug slows down gluconeogenesis—the production of glucose in the liver—and acts on metabolic pathways like AMPK.

There is a second argument, more intuitive. What ages tissues are high levels of circulating glucose adhering to proteins, a process called glycation. Lowering that level is exactly what the treatment does. Regarding price and ease of access, the circulating version claims it is sold without a prescription for about €2. That detail is not minor: it is key to its appeal.

Methylene blue: from microscope to glass of water

Methylene blue is a dye. It is used to stain samples under a microscope and in aquaculture, to treat fungal infections in tropical fish. From there to attributing mitochondrial and longevity benefits is a leap: the one from the lab to the kitchen. The repeated dose is tiny, between 1 and 2 grams per year, so a purchase of €10 or €12 becomes a lifetime supply.

The practical problem pointed out is purity: those looking to ingest it struggle to find pharmaceutical grade or USP product in Spain. The physiological problem is visible to the naked eye. It turns urine blue. A harmless cosmetic effect that, admittedly, reveals the experiment.

Side effects that are real

Here the narrative becomes grounded. Metformin, in the 850 milligram presentation, causes diarrhea, dizziness, vomiting, and nausea in many who take it, to the point that many accompany it with a gastric protector. This scenario is not rare: it is why the treatment is titrated and adjusted.

Experiences shared go in two opposite directions. One diabetic describes an initial period of intestinal discomfort that resolved in two or three days, trinc by zero side effects for three or four years. Another case speaks of much harder episodes. The distance between the two is not ideological: it is the same that separates a well-adjusted patient from one who self-medicates.

Can you get the same effects without pills?

Much of the skepticism is not against the drug, but against the idea of needing it. The argument is that fasting—intermittent and deep—and a low-carb diet activate pathways partially coincident with those of metformin, achieving the same result without a prescription and without gastrointestinal side effects. It is even claimed that a diet free of refined foods combined with fasting can reverse type 2 diabetes.

That same sector puts a limit on the drug: since it slows gluconeogenesis, it does not solve problems like fatty liver on its own. And the uncomfortable counterpoint appears. The cited trials, focused on Alzheimer's and older adults, left metformin as the big disappointment of the year. In certain contexts, negative effects are even attributed to it.

Warning on sources and self-medication

The weak point of the entire structure is documentary. The references used are commercial health blogs, not peer-reviewed trials. The question running through the issue—any source that isn't just a blog?—remains without a solid answer, and much of the enthusiasm collapses there.

It is worth adding a detail from the method's own propaganda that works more as a red flag than a recommendation: the suggestion not to confess the real use of the product to the pharmacist to avoid awkward questions. Any substance ingested without professional control, whether an antidiabetic or an industrial dye, operates in unsafe territory. That is what medical consultation is for, not anonymous advice from a website.

---

The disorienting data remains. The drug once bet on as an anti-aging elixir costs €2 and, in the cited trials, disappointed. The dye promising mitochondrial longevity sells for €10 for 25 grams and is ingested in doses of grams per year. Arithmetic was never the problem. What is missing is proof that the equation balances.